» Articles » PMID: 38133363

Nitrous Oxide Abuse: Clinical Outcomes, Pharmacology, Pharmacokinetics, Toxicity and Impact on Metabolism

Overview
Journal Toxics
Date 2023 Dec 22
PMID 38133363
Authors
Affiliations
Soon will be listed here.
Abstract

The recreational use of nitrous oxide (NO), also called laughing gas, has increased significantly in recent years. In 2022, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) recognized it as one of the most prevalent psychoactive substances used in Europe. Chronic nitrous oxide (NO) exposure can lead to various clinical manifestations. The most frequent symptoms are neurological (sensitive or motor disorders), but there are also other manifestations like psychiatric manifestations or cardiovascular disorders (thrombosis events). NO also affects various neurotransmitter systems, leading to its anesthetic, analgesic, anxiolytic and antidepressant properties. NO is very challenging to measure in biological matrices. Thus, in cases of NO intoxication, indirect biomarkers such as vitamin B12, plasma homocysteine and plasma MMA should be explored for diagnosis and assessment. Others markers, like oxidative stress markers, could be promising but need to be further investigated.

Citing Articles

First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report.

Taillefer de Laportaliere T, Redon M, Roussin A, Willemet E, Very E, Olivier J Drug Alcohol Rev. 2025; 44(3):908-912.

PMID: 39901315 PMC: 11886473. DOI: 10.1111/dar.14012.


Nitrous oxide exerts rewarding effect via regulating D1 receptor and BDNF pathway in ventral tegmental area-nucleus accumbens dopamine circuit.

Li W, Liu S, Yang S, Lin X, Zhang Z Transl Psychiatry. 2025; 15(1):34.

PMID: 39875366 PMC: 11775255. DOI: 10.1038/s41398-025-03257-y.


A fatal case of accidental asphyxia following nitrous oxide inhalation and alcohol consumption.

Liu H, Liang M, Yang Y, Ma J, Zhou Y, Dong H Forensic Sci Med Pathol. 2025; .

PMID: 39873889 DOI: 10.1007/s12024-025-00946-4.


Enhancing Differential Diagnosis Related to Oxidative Stress, Nitrous Oxide, and Nutrition by Rapid Plasma Homocysteine Measurement.

Grzych G, Zerimech F, Touze B, Descamps C, Bout M, Joncquel M J Xenobiot. 2024; 14(4):1332-1342.

PMID: 39449416 PMC: 11503375. DOI: 10.3390/jox14040075.


[Life style drug laughing gas (nitrous oxide, NO) and the dependency criteria according to ICD-10].

Diesing D, Neu P Nervenarzt. 2024; .

PMID: 39311917 DOI: 10.1007/s00115-024-01736-z.


References
1.
Walker D, Zacny J . Analysis of the reinforcing and subjective effects of different doses of nitrous oxide using a free-choice procedure. Drug Alcohol Depend. 2002; 66(1):93-103. DOI: 10.1016/s0376-8716(01)00188-0. View

2.
Caruso G, Grasso M, Fidilio A, Torrisi S, Musso N, Geraci F . Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer's Disease. Front Pharmacol. 2022; 12:809541. PMC: 8740153. DOI: 10.3389/fphar.2021.809541. View

3.
Gernez E, Bennis A, Diesnis R, Niguet J, Grzych G . Awareness of health care related to nitrous oxide abuse for diagnosis, treatment and follow-up. Ir J Med Sci. 2023; 192(6):3087-3089. DOI: 10.1007/s11845-023-03327-4. View

4.
Walsh K, Das R, Kamboj S . The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers. Int J Neuropsychopharmacol. 2016; 20(4):346-350. PMC: 5409036. DOI: 10.1093/ijnp/pyw063. View

5.
Lambooy S, Heida A, Joschko C, Nakladal D, van Buiten A, Kloosterhuis N . Selective Hepatic Knockout Aggravates Liver Damage, Endothelial Dysfunction and ROS Stress in Mice Fed a Western Diet. Int J Mol Sci. 2023; 24(8). PMC: 10138434. DOI: 10.3390/ijms24087019. View